Back to search

Article

Improving Individualized Rhabdomyosarcoma Prognosis Predictions Using Somatic Molecular Biomarkers

2024-09-05

Abstract excerpt

<h4>Purpose</h4> Molecular markers, such as FOXO1 fusion genes and TP53 and MYOD1 mutations, increasingly influence risk-stratified treatment selection for pediatric rhabdomyosarcoma (RMS). This study aims to integrate molecular and clinical data to produce individualized prognosis predictions that can further improve treatment selection. <h4>Patients and Methods</h4> Clinical variables and somatic mutation data f...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
939eda7a-25c0-5be3-b0fd-e90ff0082a23
DOI
10.1101/2024.09.04.24313032
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Improving Individualized Rhabdomyosarcoma Prognosis Predictions Using Somatic Molecular BiomarkersDOI 10.1101/2024.09.04.24313032
Select a neighboring publication to make it the new centre.